Early Experience on Intravenous Tissue Plasminogen Activator Delivery in Mobile Stroke Unit Patients with Stroke Mimics (P1.269)

Conclusions:In our early experience with MSU, treatment of stroke mimics occurred without IV-tPA related complications. This does not appear to be due to rushed decision making.Disclosure: Dr. Sheikhi has nothing to disclose. Dr. Winners has nothing to disclose. Dr. George has nothing to disclose. Dr. Russman has received personal compensation for activities with Genentech and Bristol-Myers Squibb as a scientific advisory board member. Dr. Khawaja has nothing to disclose. Dr. Uchino has nothing to disclose. Dr. Hussain has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Pre-Hospital Stroke, Tele-Stroke, and mHealth Source Type: research